Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Cancer Survival Analysis01:21

Cancer Survival Analysis

394
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
394
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Valorization of Olive Stones: Chemical Composition and Bioactivity.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Reversing T cell dysfunction in a novel <i>in vitro</i> model of T cell exhaustion reveals differential roles of RASA2.

Frontiers in immunology·2026
Same author

Natural disasters and respiratory health.

The European respiratory journal·2025
Same author

Letting Cooler Heads Prevail: The Necessity of Occupational Regulation of Heat and Smoke Exposure.

American journal of respiratory and critical care medicine·2025
Same author

A Four-Gene Signature from Blood to Exclude Bacterial Etiology of Lower Respiratory Tract Infection in Adults.

Research square·2025
Same author

Corrigendum to "Tuberculosis screening for patients on biologic Medications: A Single-Center experience and Society guideline Review, Monroe County, New York, 2018-2021" [J. Clin. Tuberc. Other Mycobact. Dis. 36 (2024) 100460].

Journal of clinical tuberculosis and other mycobacterial diseases·2025

Related Experiment Video

Updated: Jul 23, 2025

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.0K

Effectively utilizing publicly available databases for cancer target evaluation.

Daniel Croft1, Puja Lodhia2, Sofia Lourenco2

  • 1Cancer Research Horizons, The Cancer Research UK Beatson Institute, Glasgow, G61 1BD, UK.

NAR Cancer
|July 17, 2023
PubMed
Summary

Discovering effective cancer drugs requires robust target evaluation to reduce failure rates. This study highlights key, accessible databases for mining crucial data from various studies to aid precision medicine development.

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.3K
Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

492

Related Experiment Videos

Last Updated: Jul 23, 2025

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.0K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.3K
Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

492

Area of Science:

  • Oncology
  • Drug Discovery
  • Bioinformatics

Background:

  • Most cancer drug candidates fail due to poor efficacy or toxicity.
  • Effective target evaluation is crucial to minimize attrition in drug discovery.
  • Publicly available databases offer valuable data for target evaluation but can be challenging to navigate.

Purpose of the Study:

  • To compile and present key, freely accessible databases for cancer target evaluation.
  • To guide researchers on the use and limitations of these databases.
  • To support the development of precision medicine in oncology.

Main Methods:

  • Literature review and compilation of publicly available databases.
  • Categorization of databases based on data type (in vitro, in vivo, clinical).
  • Identification of comprehensive target review databases.

Main Results:

  • A curated list of accessible databases for cancer target evaluation is presented.
  • Databases housing in vitro, in vivo, and clinical study data are highlighted.
  • One-stop portals consolidating information from multiple sources are identified.

Conclusions:

  • Utilizing these highlighted databases can significantly aid cancer target evaluation.
  • Effective database mining supports the advancement of precision medicine.
  • This resource aims to reduce the high attrition rate in cancer drug discovery.